BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: In H, Ravetch E, Langdon-Embry M, Palis B, Ajani JA, Hofstetter WL, Kelsen DP, Sano T. The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging. Gastric Cancer 2018;21:1-9. [PMID: 28948368 DOI: 10.1007/s10120-017-0765-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Huang W, Li L, Li J, Yuan J, Hou P, Liu C, Ma Y, Liu X, Han Y, Liang P, Gao J. Computed Tomography Features and Clinical Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach. Front Oncol 2021;11:772636. [DOI: 10.3389/fonc.2021.772636] [Reference Citation Analysis]
2 . EXPLANATORY NOTES – SPECIFIC ANATOMICAL SITES. In: Wittekind C, Brierley JD, Lee A, Eycken E, editors. TNM Supplement. Wiley; 2019. pp. 34-156. [DOI: 10.1002/9781119263975.ch2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kim G, Friedmann P, Solsky I, Muscarella P, McAuliffe J, In H. Providing Reliable Prognosis to Patients with Gastric Cancer in the Era of Neoadjuvant Therapies: Comparison of AJCC Staging Schemata. J Gastric Cancer 2020;20:385-94. [PMID: 33425440 DOI: 10.5230/jgc.2020.20.e41] [Reference Citation Analysis]
4 Bando E, Ji X, Kattan MW, Seo HS, Song KY, Park CH, Bencivenga M, de Manzoni G, Terashima M. Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer. Cancer Med 2020;9:5708-18. [PMID: 32588982 DOI: 10.1002/cam4.3225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang N, Deng J, Wang W, Sun Z, Wang Z, Xu H, Zhou Z, Liang H. Negative lymph node count as an independent prognostic factor in stage III patients after curative gastrectomy: A retrospective cohort study based on a multicenter database. Int J Surg 2020;74:44-52. [PMID: 31874262 DOI: 10.1016/j.ijsu.2019.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Nostedt J, Gibson-Brokop L, Ghosh S, Seidler M, McCall M, Schiller D. Evaluating the utility of computed tomography of the chest for gastric cancer staging. Can J Surg 2020;63:E57-61. [PMID: 32031765 DOI: 10.1503/cjs.000319] [Reference Citation Analysis]
7 Lin JX, Yoon C, Desiderio J, Yi BC, Li P, Zheng CH, Parisi A, Huang CM, Strong VE, Yoon SS. Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy. Br J Surg 2019;106:1187-96. [PMID: 31197829 DOI: 10.1002/bjs.11181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Zhao K, Shan BQ, Gao YP, Xu JY. Role of carbon nanotracers in lymph node dissection of advanced gastric cancer and the selection of preoperative labeling time. World J Clin Cases 2022; 10(3): 870-881 [DOI: 10.12998/wjcc.v10.i3.870] [Reference Citation Analysis]
9 Zhang H, Jiang H, Zhang H, Liu J, Hu X, Chen L. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer. Int J Biol Macromol 2019;128:574-82. [PMID: 30710584 DOI: 10.1016/j.ijbiomac.2019.01.195] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
10 Zhong Q, Chen QY, Parisi A, Ma YB, Lin GT, Desiderio J, Yan S, Xie JW, Wang JB, Hou JF, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Liu ZY, Que SJ, Li P, Zheng CH, Huang CM. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study. Oncologist 2021;26:e99-e110. [PMID: 32864840 DOI: 10.1634/theoncologist.2020-0022] [Reference Citation Analysis]
11 Park JH, Yang JY, Park YH, Lee WK. The long-term prognostic difference between gastrectomy with and without preoperative chemotherapy in patients with clinical stage IV gastric cancer. Asian J Surg 2019;42:922-9. [PMID: 30685146 DOI: 10.1016/j.asjsur.2019.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jeong O, Jung MR, Kang JH, Ryu SY. Prognostic Performance of Preoperative Staging: Assessed by Using Multidetector Computed Tomography—Between the New Clinical Classification and the Pathological Classification in the Eighth American Joint Committee on Cancer Classification for Gastric Carcinoma. Ann Surg Oncol 2020;27:545-51. [DOI: 10.1245/s10434-019-07845-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
13 Liu JY, Deng JY, Zhang NN, Liu HF, Sun WL, He WT, Wang Y, Zhang L, Liang H. Clinical significance of skip lymph-node metastasis in pN1 gastric-cancer patients after curative surgery. Gastroenterol Rep (Oxf) 2019;7:193-8. [PMID: 31217983 DOI: 10.1093/gastro/goz008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yu JI, Lim DH, Lee J, Kang WK, Park SH, Park JO, Park YS, Lim HY, Kim ST, Lee SJ, Kim S, Sohn TS, Lee JH, An JY, Choi MG, Bae JM, Yoo H, Kim K. Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node-Positive Gastric Cancer Treated with Different Adjuvant Protocols. Cancer Res Treat 2019;51:876-85. [PMID: 30282450 DOI: 10.4143/crt.2018.401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Zhang Y, Yu J. The role of MRI in the diagnosis and treatment of gastric cancer. Diagn Interv Radiol 2020;26:176-82. [PMID: 32209504 DOI: 10.5152/dir.2019.19375] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Wang Y, Lei X, Liu Z, Shan F, Ying X, Li Z, Ji J. Short-term outcomes of laparoscopic versus open total gastrectomy after neoadjuvant chemotherapy: a cohort study using the propensity score matching method. J Gastrointest Oncol 2021;12:237-48. [PMID: 34012622 DOI: 10.21037/jgo-20-374] [Reference Citation Analysis]
17 Bando E, Ji X, Kattan MW, Bencivenga M, de Manzoni G, Terashima M. Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis. Cancer Med 2021;10:7561-71. [PMID: 34628732 DOI: 10.1002/cam4.4279] [Reference Citation Analysis]
18 Lombardi PM, Mazzola M, Achilli P, Aquilano MC, De Martini P, Curaba A, Gualtierotti M, Bertoglio CL, Magistro C, Ferrari G. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience. J Surg Oncol 2021;123:923-31. [PMID: 33497471 DOI: 10.1002/jso.26391] [Reference Citation Analysis]
19 Jung M, Park KH, Kim HM, Kim TS, Zhang X, Park S, Beom S, Kim HS, Cheong J, Chung HC, Soong J, Lin S, Rha SY. Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer. Gastric Cancer 2019;22:1153-63. [DOI: 10.1007/s10120-019-00971-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
20 Kumagai K, Sano T. Revised points and disputed matters in the eighth edition of the TNM staging system for gastric cancer. Jpn J Clin Oncol 2021;51:1024-7. [PMID: 33987661 DOI: 10.1093/jjco/hyab069] [Reference Citation Analysis]